ID17851A - Persenyawaan heterosiklis, produksi dan pemakaiannya - Google Patents
Persenyawaan heterosiklis, produksi dan pemakaiannyaInfo
- Publication number
- ID17851A ID17851A IDP972526A ID972526A ID17851A ID 17851 A ID17851 A ID 17851A ID P972526 A IDP972526 A ID P972526A ID 972526 A ID972526 A ID 972526A ID 17851 A ID17851 A ID 17851A
- Authority
- ID
- Indonesia
- Prior art keywords
- stands
- heterosiclic
- usage
- compounds
- production
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19110096 | 1996-07-19 | ||
JP15517797 | 1997-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID17851A true ID17851A (id) | 1998-01-29 |
Family
ID=26483246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP972526A ID17851A (id) | 1996-07-19 | 1997-07-21 | Persenyawaan heterosiklis, produksi dan pemakaiannya |
Country Status (10)
Country | Link |
---|---|
US (1) | US6211215B1 (id) |
EP (2) | EP0912562A1 (id) |
KR (1) | KR20000065227A (id) |
CN (2) | CN1077107C (id) |
AT (1) | ATE338754T1 (id) |
AU (1) | AU3461697A (id) |
CA (1) | CA2260999C (id) |
DE (1) | DE69736642T2 (id) |
ID (1) | ID17851A (id) |
WO (1) | WO1998003505A2 (id) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
BR9809172A (pt) * | 1997-05-28 | 2000-08-01 | Rhone Poulenc Rorer Pharma | Composto, composição farmacêutica, e, processos de inibir a atividade da tirosina cinase pdgf, a atividade da tirosina cinase lck, a proliferação celular, diferenciação ou liberação de mediador em um paciente, para tratar uma patologia ligada a um distúrbio hiperproliferativo, para tratar restenose e para tratar a inflamação em um paciente |
FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ATE208210T1 (de) † | 1997-08-15 | 2001-11-15 | Cephalon Inc | Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs |
CN1322139A (zh) * | 1998-10-08 | 2001-11-14 | 武田药品工业株式会社 | 阻滞激素依赖性癌症向激素非依赖性癌症转化的药物 |
US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
AU1412901A (en) * | 1999-11-16 | 2001-05-30 | Toray Industries, Inc. | Benzene derivatives and use thereof as drugs |
PE20011178A1 (es) * | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
CN1705649A (zh) | 2000-06-29 | 2005-12-07 | 艾伯特公司 | 芳基苯基杂环基硫醚衍生物及其作为抑制细胞粘附的抗炎和免疫抑制剂的用途 |
EP1310491A1 (en) * | 2000-07-19 | 2003-05-14 | Takeda Chemical Industries, Ltd. | Method for producing 1-substituted-1,2,3-triazole derivative |
HUP0400683A2 (hu) * | 2000-12-11 | 2004-06-28 | Takeda Chemical Industries, Ltd. | HER2 inhibitort tartalmazó fokozott felszívódású gyógyászati készítmény |
EP1712550A3 (en) * | 2000-12-22 | 2009-07-15 | Ortho-McNeil Pharmaceutical, Inc. | Substituted triazole diamine derivatives as kinase inhibitors |
CA2433573A1 (en) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Alkanoic acid derivatives, process for their production and use thereof |
SE0100567D0 (sv) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
US20040138160A1 (en) * | 2001-04-27 | 2004-07-15 | Kenichiro Naito | Preventive/therapeutic method for cancer |
WO2002087618A1 (fr) * | 2001-04-27 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Methode de prevention et de traitement du cancer |
MXPA03011558A (es) * | 2001-06-12 | 2004-03-26 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de desordenes metabolicos. |
US6984653B2 (en) * | 2001-10-05 | 2006-01-10 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof |
EP1444988A4 (en) | 2001-11-13 | 2007-04-25 | Takeda Pharmaceutical | CANCER AGENT |
EP1460067A4 (en) * | 2001-11-26 | 2005-12-07 | Takeda Pharmaceutical | BICYCLIC DERIVATIVE, PROCESS FOR PRODUCTION OF THE DERIVATIVE, AND USE THEREOF |
AU2003203170A1 (en) * | 2002-01-17 | 2003-07-30 | Takeda Chemical Industries, Ltd. | Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof |
DE10258168B4 (de) * | 2002-12-12 | 2005-07-07 | Infineon Technologies Ag | Integrierter DRAM-Halbleiterspeicher und Verfahren zum Betrieb desselben |
PL377712A1 (pl) | 2003-02-13 | 2006-02-06 | Wellstat Therapeutics Corporation | Związki do leczenia zaburzeń metabolicznych |
TW200505913A (en) * | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
TW200423931A (en) | 2003-04-30 | 2004-11-16 | Hoffmann La Roche | Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
US7247649B2 (en) | 2003-08-13 | 2007-07-24 | Hoffmann-La Roche Inc. | Oxazoles, their manufacture and use as pharmaceutical agents |
DE602004004156T2 (de) * | 2003-08-20 | 2007-10-11 | Eli Lilly And Co., Indianapolis | Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4-rezeptor (mc4) als agonist wirkenden peptids |
ATE361294T1 (de) * | 2003-08-20 | 2007-05-15 | Lilly Co Eli | Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagonartigen peptid (glp)-1-verbindung oder eines melanocortin-4- rezeptor-(mc4-)agonistschen peptids |
US7259262B2 (en) * | 2003-10-24 | 2007-08-21 | Hoffmann-La Roche Inc. | Arylazole derivatives, their manufacture and use as pharmaceutical agents |
TW200531688A (en) | 2004-03-05 | 2005-10-01 | Hoffmann La Roche | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
TW200612914A (en) | 2004-03-05 | 2006-05-01 | Hoffmann La Roche | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |
TW200533346A (en) | 2004-03-18 | 2005-10-16 | Hoffmann La Roche | Novel ether derivatives, their manufacture and use as pharmaceutical agents |
EP1737846A1 (en) | 2004-04-02 | 2007-01-03 | F.Hoffmann-La Roche Ag | New process for the preparation of diazine derivatives |
US7163953B2 (en) | 2004-05-25 | 2007-01-16 | Hoffmann-La Roche Inc. | Benzylether derivatives |
US7005526B2 (en) | 2004-05-25 | 2006-02-28 | Hoffmann-La Roche Inc. | Thioether derivatives |
US7288557B2 (en) | 2004-09-21 | 2007-10-30 | Hoffmann-La Roche Inc. | Triazole derivatives |
US7342030B2 (en) | 2004-09-22 | 2008-03-11 | Hoffmann-La Roche Inc. | Indole derivatives |
AR050652A1 (es) * | 2004-09-24 | 2006-11-08 | Hoffmann La Roche | Derivados de oxazol, preparacion y uso como inhibidores de la tirosina quinasa |
US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
RU2419435C2 (ru) | 2005-07-22 | 2011-05-27 | Такеда Фармасьютикал Компани Лимитед | Предотвращающий преждевременную овуляцию агент |
TW200738680A (en) * | 2005-08-04 | 2007-10-16 | Hoffmann La Roche | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
JP2009504586A (ja) * | 2005-08-08 | 2009-02-05 | エフ.ホフマン−ラ ロシュ アーゲー | ピラゾール誘導体、それらの製造及び医薬品としての使用 |
US8034954B2 (en) | 2005-12-22 | 2011-10-11 | Icagen, Inc. | Calcium channel antagonists |
WO2008034579A1 (en) * | 2006-09-20 | 2008-03-27 | F. Hoffmann-La Roche Ag | 2-heterocyclyl-5-phenoxymethylpyridine derivatives as anticancer agents |
EP2173740A4 (en) * | 2007-06-14 | 2011-09-07 | Osta Biotechnologies | INHIBITORS OF HEMOXYGENASE AND THEIR USE IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM |
WO2010026993A1 (ja) | 2008-09-03 | 2010-03-11 | 武田薬品工業株式会社 | 製剤における吸収性改善方法および吸収性が改善された製剤 |
EP2902014B1 (en) | 2012-09-26 | 2019-03-06 | Takeda Pharmaceutical Company Limited | Process for producing solid particles |
CA2995617A1 (en) * | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
CN117624052B (zh) * | 2024-01-26 | 2024-04-12 | 四川益能康生环保科技有限公司 | 一种用于捕集二氧化碳的离子液体及其制备方法 |
CN117820251B (zh) * | 2024-03-01 | 2024-05-03 | 南京桦冠生物技术有限公司 | 双α-酮酸酰胺类化合物及其组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359078A (en) * | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
JPH0678326B2 (ja) | 1990-08-23 | 1994-10-05 | フアイザー・インコーポレイテツド | 血糖低下性ヒドロキシ尿素誘導体 |
JPH08503450A (ja) | 1992-08-06 | 1996-04-16 | ワーナー−ランバート・コンパニー | 蛋白チロシンキナーゼを阻害し、かつ抗腫瘍特性を有する2−チオインドール(セレノインドール)および関連ジスルフィド(セレニド) |
IT1266582B1 (it) | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
US5466610A (en) | 1993-09-07 | 1995-11-14 | Eli Lilly And Company | Immunoassays for insulin sensitivity enhancers, insulin sensitivity enhancer antibodies, and non-thiazolidinedione insulin sensitivity enhancer compositions |
US5480896A (en) | 1994-01-27 | 1996-01-02 | American Home Products Corporation | Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents |
CA2200210A1 (en) * | 1994-09-29 | 1996-04-04 | Novartis Ag | Pyrrolo[2,3-d]pyrimidines and their use |
-
1997
- 1997-07-17 EP EP97930819A patent/EP0912562A1/en not_active Withdrawn
- 1997-07-17 WO PCT/JP1997/002479 patent/WO1998003505A2/en not_active Application Discontinuation
- 1997-07-17 KR KR1019980709698A patent/KR20000065227A/ko not_active Application Discontinuation
- 1997-07-17 EP EP02079001A patent/EP1270571B1/en not_active Expired - Lifetime
- 1997-07-17 US US09/180,955 patent/US6211215B1/en not_active Expired - Fee Related
- 1997-07-17 AU AU34616/97A patent/AU3461697A/en not_active Abandoned
- 1997-07-17 DE DE69736642T patent/DE69736642T2/de not_active Expired - Lifetime
- 1997-07-17 CN CN97195822A patent/CN1077107C/zh not_active Expired - Fee Related
- 1997-07-17 AT AT02079001T patent/ATE338754T1/de not_active IP Right Cessation
- 1997-07-17 CA CA002260999A patent/CA2260999C/en not_active Expired - Fee Related
- 1997-07-21 ID IDP972526A patent/ID17851A/id unknown
-
2001
- 2001-05-18 CN CN01119519A patent/CN1349990A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1223653A (zh) | 1999-07-21 |
US6211215B1 (en) | 2001-04-03 |
DE69736642T2 (de) | 2007-09-20 |
CA2260999A1 (en) | 1998-01-29 |
EP0912562A1 (en) | 1999-05-06 |
EP1270571B1 (en) | 2006-09-06 |
CN1349990A (zh) | 2002-05-22 |
EP1270571A1 (en) | 2003-01-02 |
WO1998003505A3 (en) | 1998-06-25 |
ATE338754T1 (de) | 2006-09-15 |
KR20000065227A (ko) | 2000-11-06 |
AU3461697A (en) | 1998-02-10 |
CA2260999C (en) | 2006-07-11 |
CN1077107C (zh) | 2002-01-02 |
DE69736642D1 (de) | 2006-10-19 |
WO1998003505A2 (en) | 1998-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID17851A (id) | Persenyawaan heterosiklis, produksi dan pemakaiannya | |
DE69636086D1 (de) | Sauerstoff enthaltende heterocyclische verbindungen | |
NO953305L (no) | Antranilsyrederivat | |
ATE339409T1 (de) | Trizyklische verbindungen | |
HK1072770A1 (en) | Bicyclic compound | |
DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
DK0597423T3 (da) | Azetidinonforbindelse og fremgangsmåde til fremstilling deraf | |
ATE285410T1 (de) | Naphthyridinderivate oder salze davon | |
DE60037766D1 (de) | Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate | |
DE69319859T2 (de) | Neue tetracyclische verbindungen | |
ATE303376T1 (de) | Tricyclische kondensierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
DE69103985T2 (de) | N-Alkylthiazolidinderivate. | |
MY134476A (en) | Aromatic compounds, their production processes and their compositions for the control of insect pests | |
DK0455899T3 (da) | Prostaglandin I-analog | |
TH14567EX (th) | สารประกอบแอโซล, การผลิตและการใช้สารเหล่านี้ |